UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000013513
Receipt No. R000007653
Scientific Title Phase 2 clinical trial of primary systemic therapy for primary breast cancer Sequential regimen of Nab-Paclitaxel followed by EC for HER2 negative breast cancer and concurrent regimen of Docetaxel/Carboplatin/Herceptin for HER2 positive breast cancer
Date of disclosure of the study information 2014/03/25
Last modified on 2014/03/25 19:58:36

No. Disposal Last modified on Item of update
1 Insert 2014/03/25 19:59:00


Contact us.